Prasad AN, Stafstrom CF, Holmes GL. Alternative epilepsy therapies: the ketogenic diet, immunoglobulins, and steroids.
Epilepsia.
1996;37:S81 - S95.
Vining EPG, Freemen JM, Ballaban-Gil K, et al. A multicenter study of the efficacy of the ketogenic diet.
Arch Neurol.
1998;55:1433 - 1437.
Freeman JM, Vining EP, Pillas DJ, et al. The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children.
Pediatrics.
1998;102:1358 - 1363.
Neelam GK, Koehler AN, McGhee B, et al. The ketogenic diet in refractory epilepsy: the experience of Children's Hospital of Pittsburgh.
Clinical Pediatrics.
2000;39:153 - 159.
Mak SC, Chi CS, Wan CJ. Clinical experience of ketogenic diet on children with refractory epilepsy.
Acta Paediatr Taiwan.
1999;40:97 - 100.
Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: a systematic review of efficacy.
Pediatrics.
2000;105:E46.
Wing RR, Vazquez JA, Ryan CM. Cognitive effects of ketogenic weight-reducing diets.
Int J Obes Relat Metab Disord.
1995;19:811 - 816.
Woody RC, Steele RW, Knapple WL, et al. Impaired neutrophil function in children with seizures treated with the ketogenic diet.
J Pediatr.
1989;115:427 - 430.
Hassan AM, Keene DL, Whiting SE, et al. Ketogenic diet in the treatment of refractory epilepsy in childhood.
Pediatr Neurol.
1999;21:548 - 552.
Herzberg GZ, Fivush BA, Kinsman SL, et al. Urolithiasis associated with the ketogenic diet.
J Pediatr.
1990;117:743 - 745.
Swink TD, Vining EP, Freeman JM. The ketogenic diet: 1997.
Adv Pediatr.
1997;44:297 - 329.
Bloom WL, Azar GJ. Similarities of carbohydrate deficiency and fasting: weight loss, electrolyte excretion, and fatigue.
Arch Intern Med.
1963;112:333 - 337.
Berry-Kravis E, Booth G, Taylor A, et al. Bruising and the ketogenic diet: evidence for diet-induced changes in platelet function.
Ann Neurol.
2001;49:98 - 103.
Ballaban-Gil K, Callahan C, O'Dell C, et al. Complications of the ketogenic diet.
Epilepsia.
1998;39:744 - 748.
Berkowitz VJ. A view on high-protein, low-carb diets [Letter response].
J Am Diet Assoc.
2000;100:1300, 1302 - 1303.
Kishi T, Fujita N, Eguchi T, et al. Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy.
J Neurol Sci.
1997;145:109 - 112.
Reynolds EH. Mental effects of anticonvulsants, and folic acid metabolism.
Brain.
1968;91:197 - 214.
Hendel J, Dam M, Gram L, et al. The effects of carbamazepine and valproate on folate metabolism.
Acta Neurol Scand.
1984;69:226 - 231.
Berg MJ, Stumbo PJ, Chenard CA, et al. Folic acid improves phenytoin pharmacokinetics.
J Am Diet Assoc.
1995;95:352 - 356.
Lewis DP, Van Dyke DC, Willhite LA, et al. Phenytoin-folic acid interaction.
Ann Pharmacother.
1995;29:726 - 735.
Lewis DP, Van Dyke DC, Stumbo PJ, et al. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate.
Ann Pharmacother.
1998;32:802 - 817.
Arenz A, Klein M, Fiehe K. Occurrence of neurotoxic 4'-O-methylpyridoxine in Ginkgo biloba leaves, ginkgo medications and Japanese ginkgo food.
Planta Med.
1996;62:548 - 551.
Said HM, Redha R, Nylander W. Biotin transport in the human intestine: inhibition by anticonvulsant drugs.
Am J Clin Nutr.
1989;49:127 - 131.
Krause KH, Bonjour JP, Berlit P, et al. Biotin status of epileptics.
Ann N Y Acad Sci.
1985;447:297 - 313.
Wahl TO, Gobuty AH, Lukert BP. Long-term anticonvulsant therapy and intestinal calcium absorption.
Clin Pharmacol Ther.
1981;30:506 - 512.
Weinstein RS, Bryce GF, Sappington LJ, et al. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment.
J Clin Endocrinol Metab.
1984;58:1003 - 1009.
Carter BL, Garnett WR, Pellock JM, et al. Effect of antacids on phenytoin bioavailability.
Ther Drug Monit.
1981;3:333 - 340.
McElnay JC, Uprichard G, Collier PS. The effect of activated dimethicone and a proprietary antacid preparation containing this agent on the absorption of phenytoin.
Br J Clin Pharmacol.
1982;13:501 - 505.
Hahn TJ, Hendin BA, Scharp CR, et al. Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults.
N Engl J Med.
1972;287:900 - 904.
Jubiz W, Haussler MR, McCain TA, et al. Plasma 1,25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs.
J Clin Endocrinol Metab.
1977;44:617 - 621.
Brodie MJ, Boobis AR, Dollery CT, et al. Rifampicin and vitamin D metabolism.
Clin Pharmacol Ther.
1980;27:810 - 814.
Williams C, Netzloff M, Folkerts L, et al. Vitamin D metabolism and anticonvulsant therapy: effect of sunshine on incidence of osteomalacia.
South Med J.
1984;77:834 - 836, 842.
Cornelissen M, Steegers-Theunissen R, Kollee L, et al. Increased incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy.
Am J Obstet Gynecol.
1993;168:923 - 928.
Cornelissen M, Steegers-Theunissen R, Kollee L, et al. Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency.
Am J Obstet Gynecol.
1993;168:884 - 888.
Hug C, McGraw CA, Bates SR, et al. Reduction of serum carnitine concentrations during anticonvulsant therapy with phenobarbital, valproic acid, phenytoin, and carbamazepine in children.
J Pediatr.
1991;119:799 - 802.
Chung S, Choi J, Hyun T, et al. Alterations in the carnitine metabolism in epileptic children treated with valproic acid.
J Korean Med Sci.
1997;12:553 - 558.
Melegh B, Trombitas K. Valproate treatment induces lipid globule accumulation with ultrastructual abnormalities of mitochondria in skeletal muscle.
Neuropediatrics.
1997;28:257 - 261.
Zelnik N, Fridkis I, Gruener N. Reduced carnitine and antiepileptic drugs: cause relationship or co-existence?
Acta Paediatr.
1995;84:93 - 95.
Coulter DL. Carnitine deficiency in epilepsy: risk factors and treatment.
J Child Neurol.
1995;10(suppl 2):S32 - S39.
Melegh B, Pap M, Morava E, et al. Carnitine-dependent changes of metabolic fuel consumption during long-term treatment with valproic acid.
J Pediatr.
1994;125:317 - 321.
De Vivo DC, Bohan TP, Coulter DL, et al. L-carnitine supplementation in childhood epilepsy: current perspectives.
Epilepsia.
1998;13:1216 - 1225.
Matsuda I, Ohtani Y. Carnitine status in Reye and Reye-like syndromes.
Pediatr Neurol.
1986;2:90 - 94.
Camina MF, Rozas I, Gomez M, et al. Short-term effects of administration of anticonvulsant drugs on free carnitine and acylcarnitine in mouse serum and tissues.
Br J Pharmacol.
1991;103:1179 - 1183.
Rodriguez-Segade S, de la Pena CA, Tutor JC, et al. Carnitine deficiency associated with anticonvulsant therapy.
Clin Chim Acta.
1989;181:175 - 181.
Freeman JM, Vining EP, Cost S, et al. Does carnitine administration improve the symptoms attributed to anticonvulsant medications?: a double-blinded, crossover study.
Pediatrics.
1994;93(6 pt 1):893 - 895.
Yarnell EY, Abascal K. An herbal formula for treating intractable epilepsy: a review of the literature.
Alt Compl Ther.
2000;6:203 - 206.
Narita Y, Satowa H, Kokubu T, et al. Treatment of epileptic patients with the Chinese herbal medicine "saiko-keishi-to" (SK).
IRCS Med Sci.
1982;10:88 - 89.
Nagakubo S, Niwa S, Kumagai N, et al. Effects of TJ-960 on Sternberg's paradigm results in epileptic patients.
Jpn J Psych Neur.
1993;47:609 - 619.
Durelli L, Mutani R. The current status of taurine in epilepsy.
Clin Neuropharmacol.
1983;6:37 - 48.
Marchesi GF, Quattrini A, Scarpino O, et al. Therapeutic effects of taurine in epilepsy: a clinical and polyphysiographic study [in Italian; English abstract].
Riv Patol Nerv Ment.
1975;96:166 - 184.
Fukuyama Y, Ochiai Y. Therapeutic trial by taurine for intractable childhood epilepsies.
Brain Dev.
1982;4:63 - 69
Fauteck JD, Schmidt H, Lerchl A, et al. Melatonin in epilepsy: First results of replacement therapy and first clinical results.
Biol Signals Recept.
1999;8:105 - 110.
Akram M, Sullivan C, Mack G, et al. What is the clinical significance of reduced manganese and zinc levels in treated epileptic patients?
Med J Aust.
1989;151:113.
Theodore WH, Hunter K, Chen R, et al. Transcranial magnetic stimulation for the treatment of seizures: A controlled study.
Neurology.
2002;59:560 - 562.
Egger J, Carter CM, Soothill JF, et al. Oligoantigenic diet treatment of children with epilepsy and migraine.
J Pediatr.
1989;114:51 - 58.
Stavem K, Kloster R, Rossberg E, et al. Acupuncture in intractable epilepsy: lack of effect on health-related quality of life.
Seizure.
2000;9:422 - 426.
Kajiyama Y, Fujii K, Takeuchi H, et al. Ginkgo seed poisoning.
Pediatrics.
2002;109:325 - 327.
Granger AS. Ginkgo biloba precipitating epileptic seizures.
Age Ageing.
2001;30:523 - 525.
Gregory PJ. Seizure associated with Ginkgo biloba? [letter].
Ann Intern Med.
2001;134:344.
Coleman M. Myoclonus in the young after 5-hydroxytryptophan [letter].
N Engl J Med.
1977;296:820.
Hagan JJ, Hatcher JP, Slade PD. The role of 5-HT1D and 5-HT1A receptors in mediating 5-hydroxytryptophan induced myoclonic jerks in guinea pigs.
Eur J Pharmacol.
1995;294:743 - 751.
Tatro D.
A to Z Drug Facts.
2nd ed. [book on CD-ROM]. St. Louis, Mo: Facts and Comparisons; 2000.
Monostory K, Vereczkey L, Levai F, et al. Ipriflavone as an inhibitor of human cytochrome P450 enzymes.
Br J Pharmacol.
1998;123:605 - 610.
Inoue F, Walsh RJ. Folate supplements and phenytoin-salicylate interaction.
Neurology.
1983;33:115 - 116.
Bourgeois BF, Dodson WE, Ferrendelli JA. Interactions between primidone, carbamazepine, and nicotinamide.
Neurology.
1982;32:1122 - 1126.
Vaddadi KS. The use of gamma-linolenic acid and linoleic acid to differentiate between temporal lobe epilepsy and schizophrenia.
Prostaglandins Med.
1981;6:375 - 379.
Tyagi A, Delanty N. Herbal remedies, dietary supplements, and seizures.
Epilepsia. 2003;44:228 - 235.
Último revisado julio 2012 por EBSCO CAM Review Board
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.
Copyright © EBSCO Publishing. All rights reserved.